Illumina, Inc. (NASDAQ:ILMN – Get Free Report) has been assigned an average recommendation of “Hold” from the seventeen brokerages that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and eight have issued a buy recommendation on the company. […]
Hedeker Wealth LLC lifted its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 13.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,360 shares of the life sciences company’s stock after buying an additional 2,165 shares […]
CenterBook Partners LP raised its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 336.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 22,123 shares of the life sciences company’s stock after purchasing an additional 17,049 shares during the period. Illumina makes up about […]
Evercore ISI reiterated their outperform rating on shares of Illumina (NASDAQ:ILMN – Free Report) in a research report released on Friday, Benzinga reports. Evercore ISI currently has a $240.00 price target on the life sciences company’s stock. A number of other analysts also recently issued reports on the stock. Citigroup dropped their price objective on […]
Girard Partners LTD. boosted its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 17.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,748 shares of the life sciences company’s stock after purchasing an additional 1,458 shares during […]